You might want to take a look at Affimed N.V. (AFMD) now

With 0.72 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.14 million shares. The 52-week range on AFMD shows that it touched its highest point at $1.11 and its lowest point at $0.22 during that stretch. It currently has a 1-year price target of $5.59. Beta for the stock currently stands at 2.07.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AFMD was down-trending over the past week, with a drop of -3.29%, but this was up by 3.26% over a month. Three-month performance surged to 32.02% while six-month performance rose 9.91%. The stock lost -35.00% in the past year, while it has lost -6.85% so far this year. A look at the trailing 12-month EPS for AFMD yields -0.85 with Next year EPS estimates of -0.61. For the next quarter, that number is -0.17. This implies an EPS growth rate of -20.95% for this year and 23.11% for next year.

Float and Shares Shorts:

At present, 149.34 million AFMD shares are outstanding with a float of 129.76 million shares on hand for trading. On Feb 15, 2024, short shares totaled 1.53 million, which was 1.02% higher than short shares on Jan 12, 2024. In addition to Dr. Andreas Harstrick M.D. as the firm’s Interim CEO, Chief Medical Officer & Member of Management Board, Dr. Wolfgang Fischer serves as its MD, COO & Member of Management Board.

Institutional Ownership:

Through their ownership of 36.77% of AFMD’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AFMD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, AFMD has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and AFMD currently yields $0.00. In the past year, AFMD’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, AFMD has a current buyback yield of $0.00. This was $0.00 for the TTM, and it was $– for the past five years.